Vanderbilt University and Bayer to evaluate new drug candidates for kidney diseases
Vanderbilt University Medical Center (VUMC) and Bayer are set to form a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Urology & Nephrology